Ginkgo Bioworks Holdings Inc
NYSE:DNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
US |
|
J
|
Jollibee Foods Corp
OTC:JBFCY
|
PH |
|
I
|
Innocan Pharma Corp
CNSX:INNO
|
IL |
|
Mitchells & Butlers PLC
LSE:MAB
|
UK |
|
aTyr Pharma Inc
NASDAQ:ATYR
|
US |
|
Ion Beam Applications SA
XBRU:IBAB
|
BE |
|
BOK Financial Corp
NASDAQ:BOKF
|
US |
Shareholder Yield
Current shareholder yield for DNA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DNA Price
Ginkgo Bioworks Holdings Inc
| Average Annual Return | -43.33% |
| Standard Deviation of Annual Returns | 46.72% |
| Max Drawdown | -99% |
| Market Capitalization | 459.3m USD |
| Shares Outstanding | 62 320 000 |
| Percentage of Shares Shorted | 8.77% |
DNA Return Decomposition
Main factors of price return
Stock Splits
DNA's latest stock split occurred on Aug 20, 2024
The company executed a 1-for-40 stock split, meaning that for every 40 shares held, investors received 1 new share.
Before the split, DNA traded at 0.234 per share. Afterward, the share price was about 7.71.
The adjusted shares began trading on Aug 20, 2024. This was the only stock split in DNA's history.
